Latest News

A selection of recent news and views from Catapult Ventures follows...

Covid-19 Pandemic Spurs Adoption and Investment in Digital Health Technologies

Gareth King, Life Science Partner with Catapult Ventures looks at some of the most exciting areas and companies leading the transformation in digital health spurred by the Covid-19 pandemic.  See the full blog in Insider here

Cytox signs licence agreement with Cardiff University for polygenic risk score technology key to development of lead product genoSCORE(TM)

2nd September 2020: Oxford & Manchester, UK. Cytox Ltd, which provides non-invasive, risk assessment and patient stratification tools for Alzheimer's disease and dementia, has signed a license agreement with Cardiff University to access t...

Clin-e-Cal launches Crowdcube campaign

Clin-e-cal uses its patented Sound Response technology to develop apps to provide real-time feedback to inhaler users & facilitate remote disease management. With thousands of downloads, they're on a mission to help the world’s 500m asth...

Catapult Ventures announces investment in digital health start-up MyHelp

22nd July 2020 - Manchester, UK.  MyHelp, a Manchester based start-up building a digital solution for mental health service providers and patients has received investment from Catapult Ventures’ GM&C Life Sciences Fund.  The c...

Catapult Ventures invests in agricultural synthetic biology start-up CroBio

15th July 2020, Alderley Park:  Catapult Ventures’ GM&C Life Sciences Fund is pleased to announce an investment in CroBio, an agricultural biotechnology start-up specialising in synthetic biology based at Alderley Par...

From our portfolio

Kanichi Research Services

Healthcare

Kanichi Research Services are developing novel non-invasive diagnostic systems that measure analy...

viewview our portfolio

Our Team

Dr Gareth King

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
Enderby
Leicester
LE19 4XT

Tel: 0116 238 8200

email